NASDAQ:KRMD - Nasdaq - US7599101026 - Common Stock - Currency: USD
3.71
-0.17 (-4.38%)
The current stock price of KRMD is 3.71 USD. In the past month the price decreased by -9.51%. In the past year, price increased by 76.67%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 82 full-time employees. The firm is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
KORU MEDICAL SYSTEMS INC
100 Corporate Drive
Mahwah NEW JERSEY 10918 US
CEO: James M. Beck
Employees: 82
Company Website: https://www.korumedical.com/
Investor Relations: https://www.korumedical.com/investors
Phone: 18006249600
The current stock price of KRMD is 3.71 USD. The price decreased by -4.38% in the last trading session.
The exchange symbol of KORU MEDICAL SYSTEMS INC is KRMD and it is listed on the Nasdaq exchange.
KRMD stock is listed on the Nasdaq exchange.
11 analysts have analysed KRMD and the average price target is 5.61 USD. This implies a price increase of 51.21% is expected in the next year compared to the current price of 3.71. Check the KORU MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
KORU MEDICAL SYSTEMS INC (KRMD) has a market capitalization of 170.07M USD. This makes KRMD a Micro Cap stock.
KORU MEDICAL SYSTEMS INC (KRMD) currently has 82 employees.
KORU MEDICAL SYSTEMS INC (KRMD) has a support level at 3.7. Check the full technical report for a detailed analysis of KRMD support and resistance levels.
The Revenue of KORU MEDICAL SYSTEMS INC (KRMD) is expected to grow by 19.29% in the next year. Check the estimates tab for more information on the KRMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
KRMD does not pay a dividend.
KORU MEDICAL SYSTEMS INC (KRMD) will report earnings on 2025-03-12, after the market close.
KORU MEDICAL SYSTEMS INC (KRMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).
The outstanding short interest for KORU MEDICAL SYSTEMS INC (KRMD) is 0.84% of its float. Check the ownership tab for more information on the KRMD short interest.
ChartMill assigns a technical rating of 6 / 10 to KRMD. When comparing the yearly performance of all stocks, KRMD is one of the better performing stocks in the market, outperforming 93.08% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to KRMD. The financial health of KRMD is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months KRMD reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 41.18% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -48.29% | ||
ROE | -67.53% | ||
Debt/Equity | 0.03 |
ChartMill assigns a Buy % Consensus number of 82% to KRMD. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 17.25% and a revenue growth 19.29% for KRMD